Your browser is no longer supported. Please, upgrade your browser.
Dyadic International, Inc.
Index- P/E- EPS (ttm)-0.38 Insider Own0.30% Shs Outstand27.53M Perf Week-3.92%
Market Cap103.11M Forward P/E- EPS next Y-0.12 Insider Trans-78.40% Shs Float19.35M Perf Month-3.16%
Income-10.40M PEG- EPS next Q-0.09 Inst Own24.90% Short Float6.39% Perf Quarter-25.66%
Sales1.70M P/S60.66 EPS this Y-10.30% Inst Trans12.75% Short Ratio1.91 Perf Half Y-38.56%
Book/sh0.93 P/B3.96 EPS next Y64.70% ROA-33.60% Target Price6.00 Perf Year-47.95%
Cash/sh0.97 P/C3.78 EPS next 5Y- ROE-35.80% 52W Range3.34 - 10.98 Perf YTD-31.60%
Dividend- P/FCF- EPS past 5Y-51.40% ROI-35.40% 52W High-66.99% Beta-0.01
Dividend %- Quick Ratio10.80 Sales past 5Y38.40% Gross Margin12.00% 52W Low8.53% ATR0.27
Employees6 Current Ratio10.80 Sales Q/Q66.70% Oper. Margin- RSI (14)41.04 Volatility4.97% 7.03%
OptionableYes Debt/Eq0.00 EPS Q/Q-48.40% Profit Margin- Rel Volume0.10 Prev Close3.68
ShortableYes LT Debt/Eq0.00 EarningsMar 30 AMC Payout- Avg Volume647.36K Price3.62
Recom2.00 SMA20-2.91% SMA50-16.85% SMA200-38.00% Volume19,513 Change-1.49%
May-26-21 08:30AM  
May-25-21 08:05AM  
May-24-21 08:30AM  
May-13-21 04:00PM  
May-03-21 08:30AM  
Apr-29-21 04:00PM  
Apr-22-21 08:30AM  
Apr-11-21 04:35AM  
Apr-08-21 05:51AM  
Mar-30-21 04:00PM  
Mar-29-21 08:30AM  
Mar-23-21 09:00AM  
Mar-22-21 09:00PM  
Mar-18-21 08:30AM  
Mar-16-21 04:00PM  
Mar-09-21 08:30AM  
Feb-15-21 08:40AM  
Feb-10-21 01:37AM  
Feb-08-21 07:35AM  
Feb-03-21 08:30AM  
Feb-02-21 09:00AM  
Jan-11-21 08:30AM  
Dec-10-20 01:19PM  
Dec-09-20 11:33AM  
Nov-30-20 05:00AM  
Nov-29-20 07:30PM  
Nov-12-20 04:30PM  
Oct-29-20 04:30PM  
Oct-28-20 08:48AM  
Oct-12-20 08:30AM  
Sep-25-20 06:25AM  
Sep-23-20 03:37PM  
Sep-17-20 08:30AM  
Sep-14-20 08:30AM  
Aug-31-20 05:00PM  
Aug-26-20 06:05AM  
Aug-13-20 04:30PM  
Aug-11-20 09:00AM  
Jul-30-20 04:00PM  
Jul-15-20 08:30AM  
Jul-10-20 08:06AM  
Jul-08-20 08:30AM  
Jul-07-20 11:02PM  
Jun-29-20 08:00AM  
Jun-11-20 08:12AM  
Jun-10-20 08:30AM  
Jun-02-20 05:25AM  
May-29-20 06:10AM  
May-27-20 12:43PM  
May-14-20 04:00PM  
May-01-20 08:03AM  
Apr-30-20 04:00PM  
Apr-20-20 08:00AM  
Apr-08-20 07:00AM  
Mar-30-20 04:00PM  
Mar-19-20 09:00AM  
Mar-18-20 04:15PM  
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and research collaborations with Jiangsu Hengrui Medicine, Serum Institute of India Pvt., Ltd., and WuXi Biologics. It also has a collaboration with TurtleTree Scientific Pte. Ltd. to develop various recombinant protein growth factors; and a partnership with Medytox, Inc. to co-develop C1 manufactured COVID-19 vaccines and/or boosters. The company was founded in 1979 and is headquartered in Jupiter, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EMALFARB MARK APresident and CEOJun 09Option Exercise1.67100,000167,0004,334,917Jun 09 05:56 PM
EMALFARB MARK APresident and CEOJun 09Sale3.7223,00085,5604,234,917Jun 09 05:56 PM
EMALFARB MARK APresident and CEOJun 08Sale3.8230,000114,6004,257,917Jun 09 05:56 PM
EMALFARB MARK APresident and CEOJun 07Sale3.9544,000173,8004,287,917Jun 09 05:56 PM
EMALFARB MARK APresident and CEOJun 04Option Exercise1.67400,000668,0004,331,917Jun 04 08:25 PM
EMALFARB MARK APresident and CEOJun 04Sale3.85132,000508,2003,931,917Jun 04 08:25 PM
Rawson Ping WangChief Financial OfficerJun 03Buy3.603,32011,9529,650Jun 04 08:26 PM
Rawson Ping WangChief Financial OfficerJun 03Buy3.601,3504,86035,850Jun 04 08:26 PM
EMALFARB MARK APresident and CEOJun 03Sale3.6126,72196,4634,063,917Jun 04 08:25 PM
Rawson Ping WangChief Financial OfficerJun 02Buy3.836,33024,2546,330Jun 04 08:26 PM
Rawson Ping WangChief Financial OfficerJun 02Buy3.7016,00059,20034,500Jun 03 04:33 PM
EMALFARB MARK APresident and CEOJun 02Sale3.7476,349285,5454,090,638Jun 04 08:25 PM
HERBST SETHDirectorJan 29Option Exercise1.9350,00096,50050,000Feb 02 05:39 PM